Kidney Cancer
Showing 1 - 25 of >10,000
Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)
Available
- Clear Cell Kidney Cancer
- +2 more
- Axitinib 5 MG
- (no location specified)
Jul 3, 2023
Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing
Recruiting
- Carcinoma
- +4 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Jun 30, 2023
Birt Hogg-Dube Syndrome and Characterization of Predisposition
Recruiting
- Kidney Neoplasms
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 22, 2022
Kidney Cancer Trial in Tampa, Atlanta, Nashville (Blood Sparing Protocol, Standard Blood Replacement)
Suspended
- Kidney Cancer
- Blood Sparing Protocol
- Standard Blood Replacement
-
Tampa, Florida
- +2 more
Aug 26, 2022
Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)
Not yet recruiting
- Prostate Cancer
- +11 more
- Guided physical exercise
- +2 more
-
Tampere, Länsi-Suomi, FinlandTampere University Hospital
Apr 3, 2023
Nivolumab in Recurring Kidney Cancer Participants
Completed
- Kidney Cancer
- Renal Cancer
- Non-Interventional
-
Tokyo, JapanLocal Institution - 0001
Oct 19, 2022
Renal Cancer Trial in Milan (Radical or partial nephrectomy)
Recruiting
- Renal Cancer
- Radical or partial nephrectomy
-
Milan, MI, ItalyIRCCS Ospedale San Raffaele
Nov 23, 2023
Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)
Not yet recruiting
- Renal Cancer
- +4 more
- HistoSonics Edison System
- (no location specified)
Apr 18, 2023
Kidney Tumor Trial in France (blood sampling for ITK dosage)
Recruiting
- Kidney Neoplasm
- blood sampling for ITK dosage
-
Marseille, France
- +4 more
Jan 6, 2023
UroCCR Database: French Research Network for Kidney Cancer
Recruiting
- Kidney Cancer
- Radical nephrectomy versus partial nephrectomy (according surgeon judgement)
-
Angers, France
- +21 more
Nov 7, 2022
Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))
Completed
- Kidney Cancer
- Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Prostate Cancer, Kidney Cancer Trial in Chambersburg (High intensity approach, Low intensity approach)
Not yet recruiting
- Prostate Cancer
- Kidney Cancer
- High intensity approach
- Low intensity approach
-
Chambersburg, PennsylvaniaWellspan
Nov 21, 2023
Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)
Active, not recruiting
- Kidney Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022
Describe Kidney Cancer Patient Population Treatment, and Results
Not yet recruiting
- Renal Cell Cancer
- +6 more
- (no location specified)
May 2, 2022
Survivorship, Prostate Cancer, Kidney Cancer Trial in Cork (Physiotherapy, Dietitian Support, Nursing and Psychosocial)
Recruiting
- Survivorship
- +5 more
- Physiotherapy
- +2 more
-
Cork, IrelandCork University Hospital
Jul 17, 2023
Oligometastatic Renal Cell Carcinoma Trial in Rome (Pembrolizumab injection plus metastasis directed treatment (surgery or RT),
Not yet recruiting
- Oligometastatic Renal Cell Carcinoma
- Pembrolizumab injection plus metastasis directed treatment (surgery or RT)
- Tumor resection or RT
-
Rome, RM, ItalyFondazione Policlinico Universitario "A. Gemelli" IRCCS
Oct 10, 2022
Frequency, Clinical Phenotype and Genetic Analysis of Heritable
Not yet recruiting
- Renal Tumor Histology
- +13 more
- Gene test
-
Shanghai, Shanghai, ChinaEthics Committee of Shanghai Renji Hospital
Sep 6, 2022
Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic
Recruiting
- Renal Tumor Histology
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)
Not yet recruiting
- Breast Cancer
- +9 more
- Assessment tool IA3-CP with SDoH
- Assessment tool IA3-CP without SDoH
- (no location specified)
May 22, 2023
MRI Guided Radiotherapy and Radiobiological Data: ISRAR Database
Not yet recruiting
- Prostate Cancer
- +4 more
- 3 MRI sequences (T2*, IVIM and Multi Echo-Gradient), without injection, are performed
- (no location specified)
Sep 18, 2023
KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors
Not yet recruiting
- Childhood Cancer
- +4 more
- (no location specified)
Nov 28, 2023
Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)
Not yet recruiting
- Urologic Cancer
- +7 more
- Electromagnetic Guided Laparoscopy
- Ultrasound
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 8, 2023
Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)
Recruiting
- Kidney Cancer
- +11 more
- 13C-Glucose
- +4 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
oncRNA Stratification of Cancer by Size and Stage
Not yet recruiting
- Kidney Cancer
- +32 more
- Exai oncRNA blood test
- (no location specified)
Apr 27, 2023
Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))
Completed
- Cancer of Kidney
- +6 more
- 124-Iodine-cG250 (124I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022